The BioWindows™ Cancer Analysis and Prevention Project
Iris BioTechnologies has launched BioWindows™ 2.0, a diagnostic and prognostic system that determines the most appropriate therapy based on genomic, family history and extensive lifestyle information for the major diseases affecting the industrialized world. Scientists are providing the genes involved in disease and Iris is providing the technologies to quickly and accurately interpret the genes behaviors.
A major overhaul of medicine is necessary to meet our needs but the system requires more involvement on our part. Disease is a result of the interaction of our genome and the environment that surrounds it - Nature and Nurture. Without good, solid information about your personal environment physicians are less effective in delivering care especially when it comes to the many varieties of cancer. Our technology will deliver the genome but you will need to personally deliver the rest.